Finding the Right Partner for Your Clinical Trial

This event is now available on demand.
Event Overview

Faced with an increasingly more competitive future, CROs are spearheading of adoption of modern clinical applications to increase efficiency, enhance collaboration, and improve clinical trial performance. Advances in clinical trial processes have arisen as a result of cross-company collaborations amongst CROs and various industry stakeholders – constrained by time and compelled by regulatory compliance – to support broader industry-wide adoption of innovations.
 
Learn more in this webinar about why CROs are advocating for operational shifts necessary to support the adoption of innovative solutions to capture data and the significance of partnering with a CRO who can support initiatives throughout the entire clinical trial continuum using innovative data capture methods and their knowledge to facilitate global submissions.

Key Learning Objectives
  • How CROs have leveraged innovation to help accelerate clinical trials.
  • The importance of a single data foundation in providing an open platform to support interoperability, delivering actionable insights while simplifying business optimization.
  • What it takes to operationalize decentralized clinical trial study designs with innovative data capture methods.
  • What it requires to have necessary oversight of global submissions to avoid incurring global study time penalties.

Who Should Attend 
  • Life Sciences executives
  • Pharmacovigilance professionals
  • Sponsor and CRO roles responsible for:
    • Clinical development planning
    • Study design
    • Country and site identification, feasibility assessment, selection, and activation
    • Clinical data management, and collection and evaluation of trial metrics
    • Project management of studies, process optimization, and operational excellence
    • Global, EMEA and country project management of studies, process optimization, and operational excellence
    • Country and site identification, selection, study package contracting, and site documentation
    • EMA regulatory submissions
  • US Central IRB roles who are responsible for generating study content for IRB submission of global studies



 
Full Agenda

Thursday, May 9th:    

10:00 am EDT    Driving Your Organizations Success and Transformational Initiatives in Clinical Trials
Ryan Kennedy, Global VP, Product Strategy, Experience, and Enablement; Oracle
Sean Roy, Senior Consulting Practice Director; Oracle
Drew Zwiebel, Global Vice President, Alliances & Channels; Oracle
Raj Modi, Senior Director, Global Customer Centre of Excellence; Oracle
   


11:00 am EDT    The Conundrum of Proliferating Data from Decentralized Clinical Trials
 

David Blackman, Executive Director Digital Trials Strategy; Oracle, and other non-Oracle speakers. 


12:00 pm EDT    How CROs Are Leveraging Innovation to Accelerate Clinical Trials
 

Non-Oracle speakers 


1:00 pm EDT    How EU 536/2014 Will Revolutionize Global Clinical Trials
Elvin Thalund, Director, Industry Strategy; Oracle, and other non-Oracle speakers



Featured Speakers

Ryan Kennedy
Ryan Kennedy
Global VP, Product Strategy, Experience, and Enablement
Oracle
Sean Roy
Sean Roy
Senior Consulting Practice Director
Oracle
Drew Zwiebel
Drew Zwiebel
Global Vice President, Alliances & Channels
Oracle
Raj Modi
Raj Modi
Senior Director, Global Customer Centre of Excellence
Oracle
David Blackman
David Blackman
Executive Director Digital Trials Strategy
Oracle
Elvin Thalund
Elvin Thalund
Director, Industry Strategy
Oracle


For any technical questions please contact Jordan Rameshjramesh@mjhlifesciences.com.